Javlor 250 mg/10 mL (vinflunine) concentrate for solution for infusion, 1 vial (Pierre Fabre) As monotherapy for the treatment of progressive Chronic thromboembolic pulmonary hypertension Pulmonary arterial hypertension (PAH), group 1 +380996042415

As monotherapy for the treatment of advanced or metastatic urothelial carcinoma (transitional cell carcinoma) of the bladder after failure of previous platinum-based chemotherapy.

The recommended dose is 320 mg/m² as a 20-minute intravenous infusion every 3 weeks.